Amoéba attracts great interest

Amoéba and its French distributor, the water treatment company Aquaprox, caught the public’s attention during the 2016’s edition of Pollutec.

Lyon, 6 October 2016 - Official opening of Amoeba’s production factory in Lyon-Chassieu on October 4th, 2016.  More than 150 guests attended the event among local politicians, investors, distributors, journalists, suppliers and employees. Jean-Jacques Selles, Mayor of Chassieu, David Kimelfeld, 1^st Vice-President of Lyon Metropole in charge of Economy and Anne Pellet, Regional Councillor Representative, were present to cut the official ribbon and show their support for Amoéba, an innovation, 100% made in France.

Lyon, 22 September 2016 – Amoéba has announced today that it has been granted a marketing authorisation for research and development for 10 industrial sites in Germany. The authorisation was issued by the German Federal Institute for Occupational Safety and Health that is one of the strictest authorities in Europe in the field of environmental and occupational protection.

Lyon, Fontana, 6 September 2016 - Amoeba has announced today that it signed a Letter of Intent (LOI), dated 14 July 2016, with AQUA-SERV, its distributor. This five-year agreement with one-year exclusive rights opens up 3 new North American states to Amoeba: California, Nevada, Arizona. This new LOI follows the one signed one year ago with Earthwise Environmental for the distribution of Amoeba’s product in 5 states (Illinois, Indiana, Wisconsin, Texas and Oklahoma). The second agreement signed in the territory of the United States demonstrates the effectiveness of Amoeba’s business strategy.

Lyon, 1 September 2016 – Amoéba, member of the Association of Water Technologies, AWT, will take part in the AWT 2016 conference and exhibition. The company will present its biological biocide to the international market at this event renowned for its focus on industrial water treatment (booth #106).

Lyon, 27 July 2016 - Amoéba announced today that it has obtained two new patents in Japan and one in Europe, all three contributing to its objective to develop new applications for its biological biocide. The first patent, issued in Japan by the Japanese Patents Office, confirms that AMOEBA’s solution has biocidal action against the pathogenic bacteria Pseudomonas, primary germ implicated in nosocomial infections acquired in health-care institutions.

Lyon, 8 June 2016 - Amoéba today announced a revised schedule for its acquisition of provisional MA. The assessment report required to obtain the provisional MA for France and Europe, initially scheduled to be delivered in May 2016, should be available during the second half of 2016.

This Thursday, 2nd June 2016, the minister for Economy, Emmanuel Macron, attended two scheduled meetings in Lyon: a meeting of the strategic committee for the “Chemistry and materials” sector and a meeting with “creative and economic innovators”. Fabrice Plasson, President of Amoéba, was invited to this meeting at the Town Hall, organised by the senator-lord mayor Gérard Collomb.